Stokes Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
3,061
+755
+33% +$258K 0.24% 63
2026
Q1
$811K Buy
2,306
+1,620
+236% +$578K 0.18% 60
2025
Q4
$225K Buy
+686
New +$218K 0.05% 78
2025
Q2
Sell
-1,655
Closed -$516K 68
2025
Q1
$516K Hold
1,655
0.13% 65
2024
Q4
$431K Sell
1,655
-45
-3% -$13.4K 0.11% 64
2024
Q3
$548K Sell
1,700
-145
-8% -$47.4K 0.14% 60
2024
Q2
$576K Hold
1,845
0.16% 60
2024
Q1
$525K Sell
1,845
-330
-15% -$96.6K 0.15% 59
2023
Q4
$626K Sell
2,175
-80
-4% -$21.8K 0.2% 59
2023
Q3
$606K Sell
2,255
-85
-4% -$21.2K 0.21% 60
2023
Q2
$520K Hold
2,340
0.18% 64
2023
Q1
$566K Buy
+2,340
New +$574K 0.19% 65
2019
Q4
Sell
-12,531
Closed -$2.42M 71
2019
Q3
$2.42M Sell
12,531
-80
-0.6% -$15.4K 1.31% 38
2019
Q2
$2.32M Sell
12,611
-602
-5% -$108K 1.32% 40
2019
Q1
$2.51M Buy
13,213
+388
+3% +$74.1K 1.51% 30
2018
Q4
$2.5M Buy
12,825
+1,080
+9% +$211K 1.73% 19
2018
Q3
$2.44M Buy
11,745
+210
+2% +$41.4K 1.49% 23
2018
Q2
$2.13M Buy
11,535
+705
+7% +$125K 1.39% 27
2018
Q1
$1.85M Buy
10,830
+1,119
+12% +$205K 1.21% 39
2017
Q4
$1.69M Buy
+9,711
New +$1.72M 1.14% 41

Other funds holding AMGN

Stokes Capital Advisors's AMGN Position: Q2 2026 in Review

Stokes Capital Advisors increased its Amgen (AMGN) stake by 33% in Q2 2026, buying an estimated $258K and bringing the position to 3,061 shares worth $1.11M. The position accounts for 0.24% of the portfolio, ranked #63.

Stokes Capital Advisors first reported a position in AMGN in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.51M in Q1 2019. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stokes Capital Advisors held 3,061 shares of Amgen worth $1.11M as of Q2 2026.
  • Stokes Capital Advisors bought 755 Amgen shares in Q2 2026, an estimated $258K.
  • Amgen made up 0.24% of Stokes Capital Advisors's portfolio in Q2 2026, its #63 holding.
  • Stokes Capital Advisors first reported a position in Amgen in Q4 2017 and has held it in 20 quarters since.
  • Stokes Capital Advisors's Amgen position peaked at $2.51M in Q1 2019.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.